HEADER MEMBRANE PROTEIN/HYDROLASE 10-AUG-15 5D5A TITLE IN MESO IN SITU SERIAL X-RAY CRYSTALLOGRAPHY STRUCTURE OF THE BETA2- TITLE 2 ADRENERGIC RECEPTOR AT 100 K COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-2 ADRENERGIC RECEPTOR,ENDOLYSIN,BETA-2 ADRENERGIC COMPND 3 RECEPTOR; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: BETA-2 ADRENORECEPTOR,BETA-2 ADRENOCEPTOR,LYSIS PROTEIN, COMPND 6 LYSOZYME,MURAMIDASE,BETA-2 ADRENORECEPTOR,BETA-2 ADRENOCEPTOR; COMPND 7 EC: 3.2.1.17; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: ADRB2, ADRB2R, B2AR; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS MEMBRANE PROTEIN, HYDROLASE, MEMBRANE PROTEIN-HYDROLASE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.-Y.HUANG,V.OLIERIC,R.WARSHAMANAGE,X.LIU,B.KOBILKA,K.KAY DIEDERICHS, AUTHOR 2 M.WANG,M.CAFFREY REVDAT 5 23-OCT-24 5D5A 1 REMARK REVDAT 4 10-JAN-24 5D5A 1 HETSYN REVDAT 3 29-JUL-20 5D5A 1 COMPND REMARK HET HETNAM REVDAT 3 2 1 HETSYN FORMUL LINK SITE REVDAT 3 3 1 ATOM REVDAT 2 02-MAR-16 5D5A 1 JRNL REVDAT 1 13-JAN-16 5D5A 0 JRNL AUTH C.Y.HUANG,V.OLIERIC,P.MA,N.HOWE,L.VOGELEY,X.LIU, JRNL AUTH 2 R.WARSHAMANAGE,T.WEINERT,E.PANEPUCCI,B.KOBILKA,K.DIEDERICHS, JRNL AUTH 3 M.WANG,M.CAFFREY JRNL TITL IN MESO IN SITU SERIAL X-RAY CRYSTALLOGRAPHY OF SOLUBLE AND JRNL TITL 2 MEMBRANE PROTEINS AT CRYOGENIC TEMPERATURES. JRNL REF ACTA CRYSTALLOGR D STRUCT V. 72 93 2016 JRNL REF 2 BIOL JRNL REFN ISSN 2059-7983 JRNL PMID 26894538 JRNL DOI 10.1107/S2059798315021683 REMARK 2 REMARK 2 RESOLUTION. 2.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1690 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.96 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 23086 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1155 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.9670 - 4.9632 0.95 2767 153 0.1787 0.2429 REMARK 3 2 4.9632 - 3.9402 0.96 2802 148 0.1887 0.2259 REMARK 3 3 3.9402 - 3.4424 0.97 2810 147 0.2007 0.2617 REMARK 3 4 3.4424 - 3.1278 0.95 2752 141 0.2288 0.2797 REMARK 3 5 3.1278 - 2.9036 0.95 2760 149 0.2495 0.2788 REMARK 3 6 2.9036 - 2.7325 0.96 2817 144 0.2620 0.3180 REMARK 3 7 2.7325 - 2.5956 0.95 2757 140 0.2983 0.3526 REMARK 3 8 2.5956 - 2.4826 0.85 2466 133 0.3284 0.3520 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 3842 REMARK 3 ANGLE : 1.487 5219 REMARK 3 CHIRALITY : 0.031 596 REMARK 3 PLANARITY : 0.019 614 REMARK 3 DIHEDRAL : 17.864 1376 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5D5A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-AUG-15. REMARK 100 THE DEPOSITION ID IS D_1000212672. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : PH 6.5-7.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0322 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23086 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.483 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.110 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2RH1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30-35 %(V/V) PEG 400, 0.1-0.2 M REMARK 280 NA2SO4, 0.1 M BIS-TRIS PROPANE PH 6.5-7.0 AND 5-7 %(V/V) 1,4- REMARK 280 BUTANEDIOL, LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.50000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 85.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.50000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 85.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -75.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1308 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1327 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -6 REMARK 465 TYR A -5 REMARK 465 LYS A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 GLN A 3 REMARK 465 PRO A 4 REMARK 465 GLY A 5 REMARK 465 ASN A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 PHE A 10 REMARK 465 LEU A 11 REMARK 465 LEU A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASN A 15 REMARK 465 ARG A 16 REMARK 465 SER A 17 REMARK 465 HIS A 18 REMARK 465 ALA A 19 REMARK 465 PRO A 20 REMARK 465 ASP A 21 REMARK 465 HIS A 22 REMARK 465 ASP A 23 REMARK 465 VAL A 24 REMARK 465 THR A 25 REMARK 465 GLN A 26 REMARK 465 GLN A 27 REMARK 465 ARG A 28 REMARK 465 ARG A 343 REMARK 465 ARG A 344 REMARK 465 SER A 345 REMARK 465 SER A 346 REMARK 465 LEU A 347 REMARK 465 LYS A 348 REMARK 465 ALA A 349 REMARK 465 TYR A 350 REMARK 465 GLY A 351 REMARK 465 ASN A 352 REMARK 465 GLY A 353 REMARK 465 TYR A 354 REMARK 465 SER A 355 REMARK 465 SER A 356 REMARK 465 ASN A 357 REMARK 465 GLY A 358 REMARK 465 ASN A 359 REMARK 465 THR A 360 REMARK 465 GLY A 361 REMARK 465 GLU A 362 REMARK 465 GLN A 363 REMARK 465 SER A 364 REMARK 465 GLY A 365 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 341 O2 PLM A 1209 1.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 165 -60.83 -98.00 REMARK 500 ILE A1029 79.00 -100.57 REMARK 500 CYS A 341 8.58 59.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 12P A 1210 DBREF 5D5A A 1 230 UNP P07550 ADRB2_HUMAN 1 230 DBREF 5D5A A 1002 1161 UNP P00720 ENLYS_BPT4 2 161 DBREF 5D5A A 263 365 UNP P07550 ADRB2_HUMAN 263 365 SEQADV 5D5A ASP A -6 UNP P07550 EXPRESSION TAG SEQADV 5D5A TYR A -5 UNP P07550 EXPRESSION TAG SEQADV 5D5A LYS A -4 UNP P07550 EXPRESSION TAG SEQADV 5D5A ASP A -3 UNP P07550 EXPRESSION TAG SEQADV 5D5A ASP A -2 UNP P07550 EXPRESSION TAG SEQADV 5D5A ASP A -1 UNP P07550 EXPRESSION TAG SEQADV 5D5A ALA A 0 UNP P07550 EXPRESSION TAG SEQADV 5D5A ARG A 16 UNP P07550 GLY 16 CONFLICT SEQADV 5D5A GLN A 27 UNP P07550 GLU 27 CONFLICT SEQADV 5D5A GLU A 187 UNP P07550 ASN 187 ENGINEERED MUTATION SEQADV 5D5A GLY A 1012 UNP P00720 ARG 12 CONFLICT SEQADV 5D5A THR A 1054 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 5D5A ALA A 1097 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 5D5A ARG A 1137 UNP P00720 ILE 137 CONFLICT SEQRES 1 A 500 ASP TYR LYS ASP ASP ASP ALA MET GLY GLN PRO GLY ASN SEQRES 2 A 500 GLY SER ALA PHE LEU LEU ALA PRO ASN ARG SER HIS ALA SEQRES 3 A 500 PRO ASP HIS ASP VAL THR GLN GLN ARG ASP GLU VAL TRP SEQRES 4 A 500 VAL VAL GLY MET GLY ILE VAL MET SER LEU ILE VAL LEU SEQRES 5 A 500 ALA ILE VAL PHE GLY ASN VAL LEU VAL ILE THR ALA ILE SEQRES 6 A 500 ALA LYS PHE GLU ARG LEU GLN THR VAL THR ASN TYR PHE SEQRES 7 A 500 ILE THR SER LEU ALA CYS ALA ASP LEU VAL MET GLY LEU SEQRES 8 A 500 ALA VAL VAL PRO PHE GLY ALA ALA HIS ILE LEU MET LYS SEQRES 9 A 500 MET TRP THR PHE GLY ASN PHE TRP CYS GLU PHE TRP THR SEQRES 10 A 500 SER ILE ASP VAL LEU CYS VAL THR ALA SER ILE GLU THR SEQRES 11 A 500 LEU CYS VAL ILE ALA VAL ASP ARG TYR PHE ALA ILE THR SEQRES 12 A 500 SER PRO PHE LYS TYR GLN SER LEU LEU THR LYS ASN LYS SEQRES 13 A 500 ALA ARG VAL ILE ILE LEU MET VAL TRP ILE VAL SER GLY SEQRES 14 A 500 LEU THR SER PHE LEU PRO ILE GLN MET HIS TRP TYR ARG SEQRES 15 A 500 ALA THR HIS GLN GLU ALA ILE ASN CYS TYR ALA GLU GLU SEQRES 16 A 500 THR CYS CYS ASP PHE PHE THR ASN GLN ALA TYR ALA ILE SEQRES 17 A 500 ALA SER SER ILE VAL SER PHE TYR VAL PRO LEU VAL ILE SEQRES 18 A 500 MET VAL PHE VAL TYR SER ARG VAL PHE GLN GLU ALA LYS SEQRES 19 A 500 ARG GLN LEU ASN ILE PHE GLU MET LEU ARG ILE ASP GLU SEQRES 20 A 500 GLY LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 21 A 500 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 22 A 500 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 23 A 500 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 24 A 500 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 25 A 500 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 26 A 500 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 27 A 500 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 28 A 500 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 29 A 500 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 30 A 500 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 31 A 500 THR GLY THR TRP ASP ALA TYR LYS PHE CYS LEU LYS GLU SEQRES 32 A 500 HIS LYS ALA LEU LYS THR LEU GLY ILE ILE MET GLY THR SEQRES 33 A 500 PHE THR LEU CYS TRP LEU PRO PHE PHE ILE VAL ASN ILE SEQRES 34 A 500 VAL HIS VAL ILE GLN ASP ASN LEU ILE ARG LYS GLU VAL SEQRES 35 A 500 TYR ILE LEU LEU ASN TRP ILE GLY TYR VAL ASN SER GLY SEQRES 36 A 500 PHE ASN PRO LEU ILE TYR CYS ARG SER PRO ASP PHE ARG SEQRES 37 A 500 ILE ALA PHE GLN GLU LEU LEU CYS LEU ARG ARG SER SER SEQRES 38 A 500 LEU LYS ALA TYR GLY ASN GLY TYR SER SER ASN GLY ASN SEQRES 39 A 500 THR GLY GLU GLN SER GLY HET BGC B 1 12 HET GLC B 2 11 HET CAU A1202 22 HET BU1 A1203 6 HET BU1 A1204 6 HET ACM A1205 4 HET CLR A1206 28 HET CLR A1207 28 HET CLR A1208 28 HET PLM A1209 17 HET 12P A1210 18 HET SO4 A1211 5 HET SO4 A1212 5 HET SO4 A1213 5 HET SO4 A1214 5 HET SO4 A1215 5 HET SO4 A1216 5 HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM CAU (2S)-1-(9H-CARBAZOL-4-YLOXY)-3-(ISOPROPYLAMINO)PROPAN- HETNAM 2 CAU 2-OL HETNAM BU1 1,4-BUTANEDIOL HETNAM ACM ACETAMIDE HETNAM CLR CHOLESTEROL HETNAM PLM PALMITIC ACID HETNAM 12P DODECAETHYLENE GLYCOL HETNAM SO4 SULFATE ION HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN CAU (S)-CARAZOLOL HETSYN 12P POLYETHYLENE GLYCOL PEG400 FORMUL 2 BGC C6 H12 O6 FORMUL 2 GLC C6 H12 O6 FORMUL 3 CAU C18 H22 N2 O2 FORMUL 4 BU1 2(C4 H10 O2) FORMUL 6 ACM C2 H5 N O FORMUL 7 CLR 3(C27 H46 O) FORMUL 10 PLM C16 H32 O2 FORMUL 11 12P C24 H50 O13 FORMUL 12 SO4 6(O4 S 2-) FORMUL 18 HOH *53(H2 O) HELIX 1 AA1 GLU A 30 PHE A 61 1 32 HELIX 2 AA2 GLU A 62 GLN A 65 5 4 HELIX 3 AA3 THR A 66 VAL A 86 1 21 HELIX 4 AA4 VAL A 86 LYS A 97 1 12 HELIX 5 AA5 PHE A 101 THR A 136 1 36 HELIX 6 AA6 THR A 146 MET A 171 1 26 HELIX 7 AA7 HIS A 178 GLU A 187 1 10 HELIX 8 AA8 ASN A 196 PHE A 208 1 13 HELIX 9 AA9 PHE A 208 GLN A 229 1 22 HELIX 10 AB1 ASN A 1002 GLU A 1011 1 10 HELIX 11 AB2 SER A 1038 GLY A 1051 1 14 HELIX 12 AB3 THR A 1059 ASN A 1081 1 23 HELIX 13 AB4 LEU A 1084 LEU A 1091 1 8 HELIX 14 AB5 ASP A 1092 GLY A 1113 1 22 HELIX 15 AB6 PHE A 1114 GLN A 1123 1 10 HELIX 16 AB7 ARG A 1125 ALA A 1134 1 10 HELIX 17 AB8 SER A 1136 THR A 1142 1 7 HELIX 18 AB9 THR A 1142 GLY A 1156 1 15 HELIX 19 AC1 TRP A 1158 LYS A 263 5 5 HELIX 20 AC2 LEU A 266 GLN A 299 1 34 HELIX 21 AC3 ARG A 304 ASN A 318 1 15 HELIX 22 AC4 PHE A 321 TYR A 326 1 6 HELIX 23 AC5 SER A 329 LEU A 340 1 12 SHEET 1 AA1 3 ARG A1014 LYS A1019 0 SHEET 2 AA1 3 TYR A1025 GLY A1028 -1 O THR A1026 N TYR A1018 SHEET 3 AA1 3 HIS A1031 THR A1034 -1 O LEU A1033 N TYR A1025 SSBOND 1 CYS A 106 CYS A 191 1555 1555 2.03 SSBOND 2 CYS A 184 CYS A 190 1555 1555 2.03 LINK SG CYS A 265 C2 ACM A1205 1555 1555 1.76 LINK SG CYS A 341 C1 PLM A1209 1555 1555 1.66 LINK O4 BGC B 1 C1 GLC B 2 1555 1555 1.47 CRYST1 107.000 170.000 40.500 90.00 106.25 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009346 0.000000 0.002724 0.00000 SCALE2 0.000000 0.005882 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025719 0.00000